- Trials with a EudraCT protocol (46)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
46 result(s) found for: Nursing management.
Displaying page 1 of 3.
EudraCT Number: 2006-001284-33 | Sponsor Protocol Number: ALS-3-06-P-401 | Start Date*: 2006-06-08 |
Sponsor Name:air liquide sante international | ||
Full Title: pain relief management by kalinox 170 bar for short-time painful procedure in paediatric patients "alivio del dolor con kalinox 170 bar en pacientes pediatricos sometidos a procedimientos doloroso... | ||
Medical condition: | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000863-98 | Sponsor Protocol Number: GlucoTab@MobileCare | Start Date*: 2018-06-25 | |||||||||||
Sponsor Name:Medical University of Graz | |||||||||||||
Full Title: A single-centre, open-label, non-controlled trial of acceptance, usability, safety and efficacy of a tablet based workflow and decision support system with incorporated basal-insulin algorithm for ... | |||||||||||||
Medical condition: Diabetes mellitus type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001201-10 | Sponsor Protocol Number: FEN-PPA-401 | Start Date*: 2004-07-26 | |||||||||||
Sponsor Name:JANSSEN-CILAG | |||||||||||||
Full Title: Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control. | |||||||||||||
Medical condition: Treatment of moderate to severe post-operative pain in subjects who have undergone an elective major abdominal or orthopaedic surgical procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002782-37 | Sponsor Protocol Number: ENT05 | Start Date*: 2005-11-17 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: A Randomised Trial of Inhaled Entonox Plus Local Anaesthesia Versus Intravenous Midazolam Plus Local Anaesthesia To Improve Pain Control During Bone Marrow Biopsy | ||
Medical condition: This study will involve a group of patients requiring diagnostic bone marrow aspiration and biopsy. The reasons for these will include haematological abnormalities of the blood count , which may be... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003866-14 | Sponsor Protocol Number: B5091007 | Start Date*: 2017-06-15 | ||||||||||||||||
Sponsor Name:Pfizer Inc. | ||||||||||||||||||
Full Title: A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older | ||||||||||||||||||
Medical condition: Primary C difficile infection (CDI) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SK (Completed) BG (Completed) SE (Completed) HU (Completed) BE (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) DE (Completed) FI (Completed) PT (Completed) ES (Completed) PL (Completed) FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002588-14 | Sponsor Protocol Number: APOTEL-02 | Start Date*: 2014-09-22 | |||||||||||
Sponsor Name:UNI-PHARMA SA | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE IV CLINICAL STUDY OF THE EFFICACY AND SAFETY OF A NEW FORMULATION OF PARACETAMOL FOR THE MANAGEMENT OF FEVER OF INFECTIOUS ORIGIN | |||||||||||||
Medical condition: Fever due to infection of the upper respiratory tract, of the lower respiratory tract, acute pyelonephritis or of the skin and soft tissues. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000529-20 | Sponsor Protocol Number: FENHYDPAI4012 | Start Date*: 2008-05-20 |
Sponsor Name:Janssen-Cilag Limited | ||
Full Title: Comparison of Ionsys® and routine care with morphine IV PCA in the management of early post-operative mobilisation, ability to mobilise and in time to Fitness For Discharge (FFD) | ||
Medical condition: Evaluation of the mobilisation characteristics, clinical use, safety and Ease of Care (EOC) of a Fentanyl Iontophoretic Transdermal PCA system (Ionsys) and morphine IV PCA for management of acute... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-003138-17 | Sponsor Protocol Number: P1200_51 | Start Date*: 2020-01-17 | |||||||||||
Sponsor Name:Cliniques universitaires Saint-Luc | |||||||||||||
Full Title: A 24 weeks proof of concept study to evaluate the clinical, MRI and synovial tissue benefit of Sarilumab in active RA patients despite TNF agents | |||||||||||||
Medical condition: Medical condition – Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002226-23 | Sponsor Protocol Number: 2013-002226-23 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Bergen, Department of Global Public Health and Primary Care | ||
Full Title: Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy | ||
Medical condition: Depression Pain Dementia | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002344-99 | Sponsor Protocol Number: SKY0402-C-203 | Start Date*: 2005-03-03 | |||||||||||
Sponsor Name:SkyePharma, Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Escalating/De-Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sustained-Release Encapsulated Bupivacaine (SKY0402) ... | |||||||||||||
Medical condition: Pain following bunionectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004418-27 | Sponsor Protocol Number: HS02/2014 | Start Date*: 2015-05-04 |
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. f. Endokrinologie und Stoffwechsel | ||
Full Title: Standardized tight blood glucose management versus usual glycaemic control in patients undergoing allogeneic stem cell transplantation – a pilot trial | ||
Medical condition: Hyperglycaemic patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001630-18 | Sponsor Protocol Number: CWL15001 | Start Date*: 2023-09-20 | |||||||||||
Sponsor Name:5med GmbH | |||||||||||||
Full Title: A randomized, parallel group, multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management and prolonged open treatment over up to 120 hours post... | |||||||||||||
Medical condition: Management of pain following orthopedic surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) BG (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000879-14 | Sponsor Protocol Number: CT/11.01 | Start Date*: 2011-06-06 |
Sponsor Name:Hellenic Oncology Research Group (H.O.R.G.) | ||
Full Title: A Phase II Trial of Pazopanib, in Relapsed and Refractory Small Cell Lung Cancer (SCLC). | ||
Medical condition: Relapsed and Refractory Small Cell Lung Cancer | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004851-19 | Sponsor Protocol Number: AAPSMCS1002 | Start Date*: 2014-07-29 |
Sponsor Name:ACORN Research, LLC | ||
Full Title: A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma. | ||
Medical condition: Surgically unresectable or metastatic chondrosarcoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004352-33 | Sponsor Protocol Number: ALLN-177-301 | Start Date*: 2018-07-18 |
Sponsor Name:Allena Pharmaceuticals, Inc. | ||
Full Title: Evaluate the Safety and Efficacy of ALLN-177 in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Placebo-Controlled Study | ||
Medical condition: Enteric Hyperoxaluria | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Completed) GB (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004087-24 | Sponsor Protocol Number: FEN-PAI-3002 | Start Date*: 2008-01-29 | |||||||||||
Sponsor Name:JANSSEN-CILAG GmbH | |||||||||||||
Full Title: Global assessment of treatment with IONSYS and its handling by patients, doctors and nursing staff in the management of acute moderate to severe post-surgery pain in hospitalised patients. | |||||||||||||
Medical condition: Acute, moderate to severe postoperative pain after elective surgery in a hospital setting in patients needing at least 24 hours strong opioids for pain therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004552-64 | Sponsor Protocol Number: 131016 | Start Date*: 2017-07-03 |
Sponsor Name:Center for Digestive Diseases, Karolinska University Hospital | ||
Full Title: MISTRAL - Mistletoe therapy in primary and recurrent inoperable pancreatic cancer - A phase III prospective, randomized, double blinded, multicenter, parallel group, placebo controlled clinical tr... | ||
Medical condition: Primary or recurrent inoperable pancreatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004480-20 | Sponsor Protocol Number: GS-US-370-1296 | Start Date*: 2015-05-28 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-blind Study of Gemcitabine and Nab-paclitaxel combined with Momelotinib in Subjects with Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma Preceded by ... | |||||||||||||
Medical condition: Untreated Metastatic Pancreatic Ductal Adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) ES (Completed) GB (Completed) CZ (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003791-13 | Sponsor Protocol Number: BP42992 | Start Date*: 2022-01-11 | |||||||||||
Sponsor Name:F. HOFFMANN - LA ROCHE LTD. | |||||||||||||
Full Title: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACODYNAMICS OF 52 WEEKS OF TREATMENT WITH BASMISANIL IN CHILDREN WITH DUP15... | |||||||||||||
Medical condition: Dup15q Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) ES (Prematurely Ended) PT (Prematurely Ended) PL (Completed) NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004672-50 | Sponsor Protocol Number: VEG110655(AGO-OVAR16) | Start Date*: 2009-05-21 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, ... | |||||||||||||
Medical condition: Advanced Ovarian Cancer (FIGO Stage II, Stage III, and Stage IV epithelial ovarian, fallopian tube, or primary peritoneal cancer) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IE (Completed) DE (Completed) AT (Completed) FR (Completed) ES (Completed) DK (Completed) BE (Completed) IT (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
